Xing Su

704 total citations
43 papers, 490 citations indexed

About

Xing Su is a scholar working on Surgery, Genetics and Epidemiology. According to data from OpenAlex, Xing Su has authored 43 papers receiving a total of 490 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Genetics and 7 papers in Epidemiology. Recurrent topics in Xing Su's work include Glioma Diagnosis and Treatment (5 papers), Tissue Engineering and Regenerative Medicine (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Xing Su is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Tissue Engineering and Regenerative Medicine (3 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Xing Su collaborates with scholars based in China, United States and Australia. Xing Su's co-authors include Qingfeng Huang, Hong‐Lin Chen, Lanchun Ni, Wei Shi, Jian Chen, Jian Chen, Yiming Mu, Lingling Guo, Qinghua Guo and Liang Xia and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Neurology.

In The Last Decade

Xing Su

42 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xing Su China 13 144 107 71 63 54 43 490
Ligia Gabriela Tătăranu Romania 16 176 1.2× 204 1.9× 49 0.7× 61 1.0× 31 0.6× 53 585
Yoshiharu Tokunaga Japan 14 265 1.8× 123 1.1× 40 0.6× 35 0.6× 53 1.0× 39 661
Alessandra Consonni Italy 18 248 1.7× 60 0.6× 37 0.5× 25 0.4× 43 0.8× 33 765
Xiaonan Liang China 13 250 1.7× 80 0.7× 75 1.1× 31 0.5× 22 0.4× 33 495
Francine Hehn de Oliveira Brazil 14 243 1.7× 68 0.6× 54 0.8× 74 1.2× 23 0.4× 40 535
Dina H. Kassem Egypt 14 209 1.5× 100 0.9× 126 1.8× 33 0.5× 14 0.3× 32 587
Pasquale Persico Italy 14 148 1.0× 192 1.8× 24 0.3× 37 0.6× 44 0.8× 40 596
Maura Argenziano Italy 15 206 1.4× 47 0.4× 60 0.8× 15 0.2× 39 0.7× 28 611

Countries citing papers authored by Xing Su

Since Specialization
Citations

This map shows the geographic impact of Xing Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Su more than expected).

Fields of papers citing papers by Xing Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Su. The network helps show where Xing Su may publish in the future.

Co-authorship network of co-authors of Xing Su

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Su. A scholar is included among the top collaborators of Xing Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Su. Xing Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Bing, Liyang Zhao, Xing Su, et al.. (2024). Exploring the most discriminative brain structural abnormalities in ASD with multi-stage progressive feature refinement approach. Frontiers in Psychiatry. 15. 1463654–1463654. 2 indexed citations
2.
Zheng, Hongwei, Hongmei Wu, Dezhi Wang, et al.. (2024). Research progress of prodrugs for the treatment of cerebral ischemia. European Journal of Medicinal Chemistry. 272. 116457–116457. 4 indexed citations
3.
Xie, Xudong, Tiantian Sun, Zhongyuan Xu, et al.. (2024). Development of Novel β-Carboline/Furylmalononitrile Hybrids as Type I/II Photosensitizers with Chemo-Photodynamic Therapy and Minimal Toxicity. Molecular Pharmaceutics. 21(7). 3553–3565. 7 indexed citations
4.
Su, Xing, Jing Wang, Ying Zhang, et al.. (2024). Hypermethylation of the glutathione peroxidase 4 promoter predicts poor prognosis in patients with hepatitis B virus-associated acute-on-chronic liver failure. Frontiers in Molecular Biosciences. 11. 1421597–1421597. 1 indexed citations
5.
Su, Xing, Zhaohui Wang, Jihui Li, et al.. (2024). Hypermethylation of the glutathione peroxidase 4 gene promoter is associated with the occurrence of immune tolerance phase in chronic hepatitis B. Virology Journal. 21(1). 72–72. 4 indexed citations
6.
Su, Xing, et al.. (2024). γ-Oryzanol Loaded Hyaluronic Acid Hydrogel Alleviates The Loss of Motor Function After Spinal Cord Injury in Mice by Inhibiting Endoplasmic Reticulum Stress. International Journal of Pharmacology. 20(2). 257–268. 1 indexed citations
7.
Zhang, Ying, Xing Su, Jine Li, et al.. (2023). F-box protein 43 promoter methylation as a novel biomarker for hepatitis B virus-associated hepatocellular carcinoma. Frontiers in Microbiology. 14. 1267844–1267844. 6 indexed citations
8.
Zhang, Lu, Ying Li, Chun-Yi Guan, et al.. (2022). Transplantation of umbilical cord-derived mesenchymal stem cells promotes the recovery of thin endometrium in rats. Scientific Reports. 12(1). 412–412. 33 indexed citations
9.
Zhang, Yuhuan, et al.. (2022). Design of High Isolation Waveguide Switch Component in Ka Band for SAR System. 1 indexed citations
10.
Zhang, Hongqiang, et al.. (2021). Application of intraoperative ultrasound in neurosurgery for hypertensive intracerebral hemorrhage. Journal of Clinical Neuroscience. 90. 251–255. 7 indexed citations
11.
Jiang, Meng, et al.. (2020). Systems Pharmacology‐Dissection of the Molecular Mechanisms of Dragon’s Blood in Improving Ischemic Stroke Prognosis. Evidence-based Complementary and Alternative Medicine. 2020(1). 4858201–4858201. 5 indexed citations
12.
Liu, Jianling, Meng Jiang, Zhihua Li, et al.. (2018). A Novel Systems Pharmacology Method to Investigate Molecular Mechanisms of Scutellaria barbata D. Don for Non-small Cell Lung Cancer. Frontiers in Pharmacology. 9. 1473–1473. 19 indexed citations
14.
Su, Xing, Xiaojiang Liu, Lanchun Ni, et al.. (2016). GFAP expression is regulated by Pax3 in brain glioma stem cells. Oncology Reports. 36(3). 1277–1284. 12 indexed citations
15.
Su, Xing, Jianguo Chen, Lanchun Ni, et al.. (2016). Inhibition of PTTG1 expression by microRNA suppresses proliferation and induces apoptosis of malignant glioma cells. Oncology Letters. 12(5). 3463–3471. 15 indexed citations
16.
17.
Vergote, I., Ana Oaknin, J.F. Baurain, et al.. (2014). A phase 1b, open-label study of trebananib in combination with paclitaxel and carboplatin in patients with ovarian cancer receiving interval or primary debulking surgery. European Journal of Cancer. 50(14). 2408–2416. 16 indexed citations
18.
Su, Xing, Qingfeng Huang, Hong‐Lin Chen, & Jian Chen. (2014). Fluorescence-guided resection of high-grade gliomas: A systematic review and meta-analysis. Photodiagnosis and Photodynamic Therapy. 11(4). 451–458. 36 indexed citations
19.
Su, Xing, Lanchun Ni, Yaohua Yan, Wei Zhao, & Jian Chen. (2013). Giant dumbbell-shaped lumbar schwannoma. The Spine Journal. 13(8). 984–984. 2 indexed citations
20.
Shi, Wei, Dekang Nie, Guohua Jin, et al.. (2012). BDNF blended chitosan scaffolds for human umbilical cord MSC transplants in traumatic brain injury therapy. Biomaterials. 33(11). 3119–3126. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026